title: [When and how to treat ventricular ectopic beats].
abstract: Ventricular ectopic beats are commonly observed in daily clinical practice, either in symptomatic or asymptomatic subjects. In many subjects these arrhythmias are casually detected during a screening visit. Their occurrence is usually associated with no clinical significance. However, in some cases the presence of ventricular ectopic beats indicates susceptibility towards life-threatening arrhythmias or ventricular dysfunction. Appropriate ECG analysis and clinical evaluation are important to detect subjects in whom effective treatment is necessary.
authors.affiliation: U.O.C. di Cardiologia, Ospedale di Dolo (VE). daniele.deste@ulss13mirano.ven.it
authors.forename: Daniele
authors.initials: D
authors.lastname: D'Este
authors.forename: Maria Domenica
authors.initials: MD
authors.lastname: Sorbo
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis; D004562:Electrocardiography; D016700:Encainide / Q000008:administration & dosage / Q000627:therapeutic use; D005080:Exercise Test; D006801:Humans; D015994:Incidence; D015995:Prevalence; D011379:Prognosis; D011405:Propafenone / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D026941:Sodium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D013177:Sports; D018879:Ventricular Premature Complexes / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D026941:Sodium Channel Blockers; D011405:Propafenone; D016700:Encainide